Literature DB >> 30622025

Recent applications of hydantoin and thiohydantoin in medicinal chemistry.

SeoHyun Cho1, Seok-Ho Kim2, Dongyun Shin3.   

Abstract

Hydantoin, imidazolidine-2,4-dione, is a non-aromatic five-membered heterocycle, which is considered a valuable, privileged scaffold in medicinal chemistry. The importance of the hydantoin scaffold in drug discovery has been reinforced by several medicines in clinical use, such as phenytoin, nitrofurantoin, and enzalutamide. Hydantoin has five potential substituent sites, including two hydrogen bond acceptors and two hydrogen bond donors. Two additional attractive features of hydantoin scaffolds are their synthetic feasibility for core scaffolds via established cyclization reactions and their ease of accepting various substituents. Because of these characteristics, many hydantoin derivatives with different substituents have been designed and synthesized and exhibit a broad spectrum of biological and pharmacological activities against, for example, cancers, microbial infections, metabolic diseases, and epilepsy. In this review, recent contributions of hydantoin, thiohydantoin, and selenohydantoin scaffolds to medicinal chemistry are described; some major compounds are presented to emphasize their importance, and their structure-activity relationships (SARs) are briefly addressed. Major discussions are devoted to the structural features or novelty of each scaffold and its SAR. The publications in this review encompass those from 2012 to 2018.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Heterocycle; Hydantoin; Imidazolidine-2,4-dione; Medicinal chemistry; Thiohydantoin

Mesh:

Substances:

Year:  2018        PMID: 30622025     DOI: 10.1016/j.ejmech.2018.12.066

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Molecular Rearrangement of Pyrazino[2,3-c]quinolin-5(6H)-ones during Their Reaction with Isocyanic Acid.

Authors:  Antonín Klásek; Antonín Lyčka; Filip Křemen; Aleš Růžička; Michal Rouchal
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

2.  A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer's Disease.

Authors:  Isabella Bolognino; Nicola Giangregorio; Leonardo Pisani; Modesto de Candia; Rosa Purgatorio; Annamaria Tonazzi; Cosimo Damiano Altomare; Saverio Cellamare; Marco Catto
Journal:  Molecules       Date:  2019-11-25       Impact factor: 4.411

3.  Preliminary Studies of Antimicrobial Activity of New Synthesized Hybrids of 2-Thiohydantoin and 2-Quinolone Derivatives Activated with Blue Light.

Authors:  Agnieszka Kania; Waldemar Tejchman; Anna M Pawlak; Krystian Mokrzyński; Bartosz Różanowski; Bogdan M Musielak; Magdalena Greczek-Stachura
Journal:  Molecules       Date:  2022-02-05       Impact factor: 4.411

4.  [3+2]-Cycloaddition of azomethine ylides to 5-methylidene-3-aryl-2-сhalcogen-imidazolones: access to dispiro indolinone-pyrrolidine-imidazolones.

Authors:  Maxim E Kukushkin; Alexandra A Kondratieva; Nikita A Karpov; Dmitry E Shybanov; Viktor A Tafeenko; Vitaly A Roznyatovsky; Yuri K Grishin; Anna A Moiseeva; Nikolai V Zyk; Elena K Beloglazkina
Journal:  R Soc Open Sci       Date:  2022-03-09       Impact factor: 2.963

5.  Development of Novel 1,3-Disubstituted-2-Thiohydantoin Analogues with Potent Anti-Inflammatory Activity; In Vitro and In Silico Assessments.

Authors:  Salma M Khirallah; Heba M M Ramadan; Ahmed Shawky; Safa H Qahl; Roua S Baty; Nada Alqadri; Amnah Mohammed Alsuhaibani; Mariusz Jaremko; Abdul-Hamid Emwas; Essa M Saied
Journal:  Molecules       Date:  2022-09-23       Impact factor: 4.927

6.  Cu-catalyzed N-3-Arylation of Hydantoins Using Diaryliodonium Salts.

Authors:  Linn Neerbye Berntsen; Ainara Nova; David S Wragg; Alexander H Sandtorv
Journal:  Org Lett       Date:  2020-03-23       Impact factor: 6.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.